PPAR-contributes to the anti-inflammatory activity of verbascoside in a model of inflammatory bowel disease in mice

Salvatore Cuzzocrea, Emanuela Esposito, Emanuela Mazzon, Irene Paterniti, Roberto Dal Toso, Giovanna Pressi, Rocco Caminiti

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The previous results suggest that peroxisome proliferator-activated receptor-alpha (PPAR)-, an intracellular transcription factor activated by fatty acids, plays a role in control of inflammation. There is persuasive epidemiological and experimental evidence that dietary polyphenols have anti-inflammatory activity. In this regard, it has been demonstrated that verbascoside (VB) functions as intracellular radical scavenger and reduces the microscopic and macroscopic signs of experimental colitis. With the aim to characterize the role of PPAR-in VB-mediated anti-inflammatory activity, we tested the efficacy of VB in an experimental model of inflammatory bowel disease induced by dinitrobenzene sulfonic acid, comparing mice lacking PPAR-(PPAR-KO) with wild type (WT) mice. Results indicate that VB-mediated anti-inflammatory activity is weakened in PPAR-KO mice, compared to WT controls, especially in the inhibition of neutrophil infiltration, intestinal permeability and colon injury. These results indicate that PPAR-can contribute to the anti-inflammatory activity of VB in inflammatory bowel disease.

Original languageEnglish
Article number917312
JournalPPAR Research
DOIs
Publication statusPublished - 2010

Fingerprint

PPAR alpha
Inflammatory Bowel Diseases
Anti-Inflammatory Agents
Dinitrobenzenes
Sulfonic Acids
Neutrophil Infiltration
Polyphenols
Colitis
acteoside
Permeability
Colon
Transcription Factors
Theoretical Models
Fatty Acids
Inflammation
Wounds and Injuries

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Drug Discovery

Cite this

PPAR-contributes to the anti-inflammatory activity of verbascoside in a model of inflammatory bowel disease in mice. / Cuzzocrea, Salvatore; Esposito, Emanuela; Mazzon, Emanuela; Paterniti, Irene; Dal Toso, Roberto; Pressi, Giovanna; Caminiti, Rocco.

In: PPAR Research, 2010.

Research output: Contribution to journalArticle

Cuzzocrea, Salvatore ; Esposito, Emanuela ; Mazzon, Emanuela ; Paterniti, Irene ; Dal Toso, Roberto ; Pressi, Giovanna ; Caminiti, Rocco. / PPAR-contributes to the anti-inflammatory activity of verbascoside in a model of inflammatory bowel disease in mice. In: PPAR Research. 2010.
@article{2fe8d49bae1e402c9640d3226e3721b2,
title = "PPAR-contributes to the anti-inflammatory activity of verbascoside in a model of inflammatory bowel disease in mice",
abstract = "The previous results suggest that peroxisome proliferator-activated receptor-alpha (PPAR)-, an intracellular transcription factor activated by fatty acids, plays a role in control of inflammation. There is persuasive epidemiological and experimental evidence that dietary polyphenols have anti-inflammatory activity. In this regard, it has been demonstrated that verbascoside (VB) functions as intracellular radical scavenger and reduces the microscopic and macroscopic signs of experimental colitis. With the aim to characterize the role of PPAR-in VB-mediated anti-inflammatory activity, we tested the efficacy of VB in an experimental model of inflammatory bowel disease induced by dinitrobenzene sulfonic acid, comparing mice lacking PPAR-(PPAR-KO) with wild type (WT) mice. Results indicate that VB-mediated anti-inflammatory activity is weakened in PPAR-KO mice, compared to WT controls, especially in the inhibition of neutrophil infiltration, intestinal permeability and colon injury. These results indicate that PPAR-can contribute to the anti-inflammatory activity of VB in inflammatory bowel disease.",
author = "Salvatore Cuzzocrea and Emanuela Esposito and Emanuela Mazzon and Irene Paterniti and {Dal Toso}, Roberto and Giovanna Pressi and Rocco Caminiti",
year = "2010",
doi = "10.1155/2010/917312",
language = "English",
journal = "PPAR Research",
issn = "1687-4757",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - PPAR-contributes to the anti-inflammatory activity of verbascoside in a model of inflammatory bowel disease in mice

AU - Cuzzocrea, Salvatore

AU - Esposito, Emanuela

AU - Mazzon, Emanuela

AU - Paterniti, Irene

AU - Dal Toso, Roberto

AU - Pressi, Giovanna

AU - Caminiti, Rocco

PY - 2010

Y1 - 2010

N2 - The previous results suggest that peroxisome proliferator-activated receptor-alpha (PPAR)-, an intracellular transcription factor activated by fatty acids, plays a role in control of inflammation. There is persuasive epidemiological and experimental evidence that dietary polyphenols have anti-inflammatory activity. In this regard, it has been demonstrated that verbascoside (VB) functions as intracellular radical scavenger and reduces the microscopic and macroscopic signs of experimental colitis. With the aim to characterize the role of PPAR-in VB-mediated anti-inflammatory activity, we tested the efficacy of VB in an experimental model of inflammatory bowel disease induced by dinitrobenzene sulfonic acid, comparing mice lacking PPAR-(PPAR-KO) with wild type (WT) mice. Results indicate that VB-mediated anti-inflammatory activity is weakened in PPAR-KO mice, compared to WT controls, especially in the inhibition of neutrophil infiltration, intestinal permeability and colon injury. These results indicate that PPAR-can contribute to the anti-inflammatory activity of VB in inflammatory bowel disease.

AB - The previous results suggest that peroxisome proliferator-activated receptor-alpha (PPAR)-, an intracellular transcription factor activated by fatty acids, plays a role in control of inflammation. There is persuasive epidemiological and experimental evidence that dietary polyphenols have anti-inflammatory activity. In this regard, it has been demonstrated that verbascoside (VB) functions as intracellular radical scavenger and reduces the microscopic and macroscopic signs of experimental colitis. With the aim to characterize the role of PPAR-in VB-mediated anti-inflammatory activity, we tested the efficacy of VB in an experimental model of inflammatory bowel disease induced by dinitrobenzene sulfonic acid, comparing mice lacking PPAR-(PPAR-KO) with wild type (WT) mice. Results indicate that VB-mediated anti-inflammatory activity is weakened in PPAR-KO mice, compared to WT controls, especially in the inhibition of neutrophil infiltration, intestinal permeability and colon injury. These results indicate that PPAR-can contribute to the anti-inflammatory activity of VB in inflammatory bowel disease.

UR - http://www.scopus.com/inward/record.url?scp=77955365610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955365610&partnerID=8YFLogxK

U2 - 10.1155/2010/917312

DO - 10.1155/2010/917312

M3 - Article

C2 - 20671911

AN - SCOPUS:77955365610

JO - PPAR Research

JF - PPAR Research

SN - 1687-4757

M1 - 917312

ER -